The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 36, No. 4, pp. 707-712. DOI 10.1345/aph.1A184
© 2002 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, L.
Right arrow Articles by Kubes, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, L.
Right arrow Articles by Kubes, K.

Research Articles

Serotonergic agents in the treatment of fibromyalgia syndrome

LJ Miller and KL Kubes

OBJECTIVE: To evaluate literature that discusses the treatment of fibromyalgia syndrome (FMS) with agents that involve the neurotransmitter serotonin. DATA SOURCES: Biomedical literature accessed through MEDLINE (1966-August 2001) and International Pharmaceutical Abstracts. DATA SYNTHESIS: The cause and pathophysiology of FMS remain elusive, although abnormalities in the serotonin pathway have been implicated. Several serotonergic agents have been studied for use in FMS. Trials and case reports focusing on the use of newer agents: the selective serotonin reuptake inhibitors, venlafaxine and tramadol, were reviewed. CONCLUSIONS: Current research suggests that the serotonergic agents may reduce at least some of the symptoms of FMS. However, medications that act on multiple neurotransmitters may prove to be more effective in symptom management. Additional long-term studies are required in order to validate these results.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
P. B Wood, A. S Kablinger, and G. S Caldito
Open Trial of Pindolol in the Treatment of Fibromyalgia
Ann. Pharmacother., November 1, 2005; 39(11): 1812 - 1816.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
K. Sayar, G. Aksu, I. Ak, and M. Tosun
Venlafaxine Treatment of Fibromyalgia
Ann. Pharmacother., November 1, 2003; 37(11): 1561 - 1565.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2002 by Harvey Whitney Books Company.